(Q40511478)

21 September 2017

title

Efficacy of mesalazine in the treatment of symptomatic diverticular disease (English)

1 reference

21 September 2017

Francesco Di Mario

1

1 reference

21 September 2017

Giovanni Aragona

2

1 reference

21 September 2017

Gioacchino Leandro

3

1 reference

21 September 2017

Giuseppe Comparato

4

1 reference

21 September 2017

Libera Fanigliulo

5

1 reference

21 September 2017

Lucas G Cavallaro

6

1 reference

21 September 2017

Giulia M Cavestro

7

1 reference

21 September 2017

Veronica Iori

8

1 reference

21 September 2017

Marta Maino

9

1 reference

21 September 2017

Alì M Moussa

10

1 reference

21 September 2017

Alessandro Gnocchi

11

1 reference

21 September 2017

Giancarlo Mazzocchi

12

1 reference

21 September 2017

Angelo Franzé

13

1 reference

21 September 2017

publication date

1 March 2005

1 reference

Digestive Diseases and Sciences

21 September 2017

published in

1 reference

21 September 2017

volume

50

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

581-586

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-005-2478-z

21 September 2017

exact match

0 references

cites work

Influence on symptoms and transit-time of Vi-SiblinR in diverticular disease

1 reference

12 December 2020

Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly

1 reference

12 December 2020

Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology

1 reference

12 December 2020

Psyllium therapy in the irritable bowel syndrome. A double-blind trial

1 reference

12 December 2020

Endoscopic crescentic fold disease of the sigmoid colon: the clinical and histopathological spectrum of a distinctive endoscopic appearance

1 reference

12 December 2020

Ulcerative colitis with relative sparing of the rectum. Clinical features, histology, and prognosis

1 reference

12 December 2020

Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group

1 reference

12 December 2020

Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon

1 reference

12 December 2020

Diagnosis and treatment of diverticular disease: results of a consensus development conference. The Scientific Committee of the European Association for Endoscopic Surgery

1 reference

12 December 2020

Treatment of symptomatic diverticular disease with a high-fibre diet

1 reference

12 December 2020

Crohn's disease of the colon and its distinction from diverticulitis

1 reference

12 December 2020

Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon

1 reference

12 December 2020

Evaluation of the effect of rifaximin in colon diverticular disease by means of lactulose hydrogen breath test

1 reference

12 December 2020

Effects of antimicrobial therapy on faecal bulking

1 reference

12 December 2020

Medical progress. Diverticular disease of the colon

1 reference

12 December 2020

Paracolic fistulous tracts in diverticulitis and granulomatous colitis

1 reference

12 December 2020

Nitric oxide as a modulator of intestinal water and electrolyte transport

1 reference

12 December 2020

Granulomatous Colitis in Association with Diverticula

1 reference

12 December 2020

Cytokines in inflammatory bowel disease

1 reference

12 December 2020

[Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4 year follow-up results]

1 reference

12 December 2020

[The rifaximin therapy and prophylaxis of episodes of acute diverticulitis].

1 reference

12 December 2020

Diverticular disease and chronic idiopathic inflammatory bowel disease: associations and masquerades

1 reference

12 December 2020

Coexistent Crohn's disease and sigmoid diverticulosis

1 reference

12 December 2020

A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome

1 reference

12 December 2020

Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial

1 reference

12 December 2020

REVISED CONCEPTS ON DIVERTICULAR DISEASE OF THE COLON. II. SO-CALLED DIVERTICULITIS: DIVERTICULAR SIGMOIDITIS AND PERISIGMOIDITIS; DIVERTICULAR ABSCESS, FISTULA, AND FRANK PERITONITIS

1 reference

12 December 2020

Pathogenesis of diverticulitis complicating granulomatous colitis

1 reference

12 December 2020

Diverticular disease-associated chronic colitis

1 reference

12 December 2020

10.1007/S10620-005-2478-Z

Identifiers

DOI

1 reference

21 September 2017

1 reference